Innovation

KAVI-Institute of Clinical Research (KAVI-ICR) was awarded the 2022 International AIDS Vaccine Initiative (IAVI) External Quality Assessment (EQA) Awards For Tier 1 and Tier 2. This is the second year running that the Institute has won this prestigious award. It recognises the best performing laboratories amongst their Clinical Research Centres in Africa. The Institute at the University of Nairobi, KNH Campus was first among Tier 1 and the Kangemi site among Tier 2.

The Chair of the Department of Medical Microbiology & Immunology and the Director of the KAVI-ICR hosted a round table discussion with Gilead Sciences, led by Christopher Whitfield, General Manager of Gilead Sciences, and Dr. Summer Sitima, General Manager of Gilead Sciences in Central and East Africa, to discuss the possibility of a partnership and collaboration. They were joined by AMSUN representatives who represented medical students and the RADA UNESCO-UoN team led by Lisbeth Kageni.

Chair of the Department Dr. Marianne Mureithi recently attended the Falling Walls Female Science Talents International Spring Gathering 2022 in Berlin, Germany.